© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Procaterol Hydrochloride represents a synthetic compound commonly used in medicine to support respiratory health. Developed as a selective β2-adrenergic receptor agonist, it gained ground in the treatment of patients experiencing bronchial asthma or chronic obstructive pulmonary disease. Each lot of this material typically appears as a white or light yellow solid, produced mainly in flakes or powdered form. This approach to synthesis and purification reflects a wider trend in pharmaceutical manufacturing, where material form and purity play a central role in ensuring safety and reliable dosing. Material safety remains under high scrutiny, with many international guidelines requiring an in-depth review of chemical and physical features along with robust protections for anyone involved in production, handling, or use. The evolution of medications like procaterol hydrochloride tracks the progress of chemical synthesis, regulatory science, and patient needs over recent decades.
The molecular formula for procaterol hydrochloride is C16H22N2O3·HCl, which shows the presence of hydrochloride salt to boost the stability and water solubility of the main compound. Its molecular weight clocks in at about 326.8 g/mol. Under standard conditions, dense, crystalline powder dominates the visual profile, rarely deviating from clean white to a faint yellow. Density measurements usually approach 1.2 g/cm³, depending on lot-specific hydration and processing differences. The layered structure of the solid reflects well-ordered molecular stacking supported by a robust hydrogen bonding network from the hydrochloride function. Such attention to structure ensures that this compound can dissolve easily when called upon for solution preparations, with the final active pharmaceutical ingredient ready for clinical use. Years working in quality control confirm time and again how minor tweaks to crystal structure lead to measurable changes in performance, absorption, and shelf stability. The aromatic core, supported by compact functional groups, contributes to the relatively high melting point—usually recorded near 220°C with decomposition—another sign of the compound’s resilience and well-constrained molecular environment.
Manufacturers handle batch-to-batch variation by enforcing strict internal standards patterned on pharmacopeia guidelines. Each batch comes labeled with a full panel of specifications, including content assay percentages, related substances, moisture levels, and particle size distribution. For those preprocessing raw materials, powder form remains the norm, though flake or granular forms do appear in large-scale procurement, depending on customer requirements downstream. Regulatory authorities worldwide track the shipment and import/export of this compound, assigning it the Harmonized System (HS) Code 2934999090. Customs authorities rely on this code to distinguish pharmaceutical intermediates from other organic chemicals in transit, tracing every entry point, and enforcing compliance with international safety conventions—a critical check on illegal trade or improper use. My own experience working alongside customs officers during raw material handling confirms how attention to HS code and batch certificate saves headaches for importers and manufacturers alike.
As a raw material, procaterol hydrochloride lands on the desk or loading bay floor as a well-sealed, desiccated solid. Powder, pearls, or flakes each serve slightly different purposes depending on the further step in production—tableting, compounding, or research. Larger operations favor flakes for ease of large-scale transport and minimized dust. Smaller, research-focused labs appreciate powder for its flexibility in making solutions or test doses. The material’s hydrated hydrochloride nature also means marked solubility in water, ethanol, and various organic solvents. That flexibility cuts down on prep time, a fact clear in any busy pharmaceutical compounding center. Chemically, the compound remains stable under normal storage, away from direct light and moisture, though extended heat exposure triggers breakdown into less active forms. In hands-on production work, every lost gram from improper storage or excessive handling cuts into yield and impacts downstream cost and efficacy.
Handling procaterol hydrochloride in its raw state requires a clear respect for both its potency and potential hazards. Prolonged contact with dust or solution invites harmful reactions in sensitive individuals—eye and skin irritation rank among the more common effects, alongside headaches or shortness of breath after repeated inhalation of dust. Safety Data Sheets (SDS) spell out the need for gloves, goggles, lab coats, and good ventilation, lessons reinforced through every official training or routine production drill. Lapses in safety lead to documented cases of occupational exposure, with some cases escalating to acute health emergencies if fast action fails to intervene. Hazard labels follow every container, listing risks such as inhalation, skin absorption, and accidental ingestion. In years spent in chemical logistics, the steady push toward ever safer packaging, labeling, and employee health tracking speaks to hard lessons learned across the industry. Awareness and accountability bring results: routine audits and peer-to-peer safety updates cut down on preventable incidents in every lab where these chemicals cycle through the workflow.
Procaterol hydrochloride stands as one small chapter in the larger story of modern medicine’s efforts against chronic respiratory disease. Matching the compound’s chemical elegance with responsible production and transparent distribution practices challenges every link in the supply chain. Chronic underreporting of counterfeit or off-spec material presents a challenge, as unscrupulous suppliers attempt to cut corners or skirt regulations. Close tracking of batch numbers, certificates of analysis, and robust third-party testing address many of these issues, yet globalized trade and increased demand stress even well-organized companies. Newer technological safeguards, like blockchain traceability or compound-specific chemical fingerprinting, promise further assurance—protecting everyone from procurement to patient. My own work with analytic labs has underlined the need for ongoing investment in training, equipment, and honest communication, from the first batch of raw material right through to the time medicine reaches the pharmacy shelf. Embracing these changes means not just compliance, but genuine safety and reliability for workers, suppliers, physicians, and—most of all—patients who depend on every dose.
